STAT Plus: HHS criticizes Lilly for seeking to curtail discounts for safety-net hospitals
In a stern rebuke, the Department of Health and Human Services has taken Eli Lilly…
Author: STAT
STAT Virtual Event: The ESMO Recap, Live!
Editor’s note: A live stream of the event will be embedded above at 1:30 p.m….
STAT Plus: Public funding underwrote much of the development of J&J’s drug for TB, analysis finds
Amid ongoing debate over taxpayer dollars used to generate medicines, a new analysis contends that…
STAT Plus: Teladoc’s tussle with Amwell raises questions about defining property rights in digital health
The field of health tech is facing a big question: Can it establish strong patent…
STAT Plus: Pharmalittle: FDA to set new standard for Covid-19 vaccine; J&J starts a one-shot vaccine trial
Hello, everyone, and welcome to the middle of the week. Already, you say? Well, the…
Opinion: America’s mental health care system fell short for my brother. Access to that care should be a legal right for all
The year 2020 has put an exclamation point on the need for robust mental health…
STAT Plus: Q&A: Vivek Murthy, a top Biden adviser, on Covid-19 vaccines, the drug industry, and the future of public health
WASHINGTON — After a years-long hiatus, Vivek Murthy is back in the political spotlight. As…
Opinion: Fast, low-cost testing is essential for averting a second wave of Covid-19
Since the first Covid-19 cases emerged in the U.S. in early 2020, attitudes toward coronavirus…
When AI is the opposite of sinister: An MIT researcher is held up as model of how algorithms can benefit humanity
In June, when MIT artificial intelligence researcher Regina Barzilay went to Massachusetts General Hospital for…
STAT Plus: FDA proposes a ‘modest’ change to a rule for policing off-label marketing
After years of controversy, the Food and Drug Administration has issued a proposed rule to…
STAT Plus: Novartis sells bonds tied to expanding access to medicines in poor countries
In a first-of-its-kind move by a large drug maker, Novartis (NVS) raised approximately $2.1 billion…
Opinion: Cancer survivor: Don’t forget that accolade when it comes to Ruth Bader Ginsburg’s remarkable life
Supreme Court Associate Justice Ruth Bader Ginsburg, who died last week at the age of…
STAT Plus: In another health bet, Amazon expands virtual care program for employees
Amazon is expanding a virtual health care initiative for employees called Amazon Care on Tuesday…
STAT+ Conversations: The D.C. Diagnosis
Each week, STAT Plus subscribers get exclusive access to live discussions with STAT reporters and…
STAT Plus: Pharmalittle: Medicare wouldn’t cover emergency-use Covid-19 vaccines; 156 countries join WHO vaccine effort
Top of the morning to you, and a fine one it is. Baby blue skies…
STAT Plus: Coming for the king: Keytruda dominates the immunotherapy market, but challengers are lining up
Keytruda is the immunotherapy king. In the U.S., the Merck anti-PD1 checkpoint inhibitor is approved…
Opinion: If donating a kidney to a stranger is ethical and allowable, taking part in a Covid-19 challenge trial should be, too
A few months ago, one of us (S.B.) found himself staring up into the bright…
New research shows many children with mental health conditions don’t get follow-up care
A large new study finds that mental health care for many children in the U.S….
Joe Biden’s campaign-trail challenge: Casting doubt on a Trump vaccine without fueling broader vaccine skepticism
WASHINGTON — To Joe Biden and his campaign allies, it’s a straightforward distinction: They trust…
.jpg)
The Road Ahead: Charting the coronavirus pandemic over the next 12 months — and beyond
Think back through the pandemic. Think about the moments that stand out as beacons in…
STAT Plus: The world is racing toward Covid-19 drugs. In normal times, it takes years to get new antivirals out the door
Researchers may be racing to develop new Covid-19 treatments, but normally it has taken slightly…
STAT Plus: Legend Biotech CEO detained in China as part of investigation
Legend Biotech’s man in charge will be working from home for the time being. The…
STAT Plus: Senators urge bankruptcy judge to prevent Purdue from paying its CEO a $3.5 million bonus
A group of U.S. senators is urging a bankruptcy judge to prevent Purdue Pharma from…
64 high-income nations join effort to expand global access to Covid-19 vaccines, but U.S. and China do not
Countries representing about 64% of the world population have signed up to expand global access…
STAT Plus: Pharmalittle: Azar bars FDA from signing new rules; AstraZeneca reveals Covid-19 vaccine trial protocol
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Teladoc accuses Amwell of infringing on its telehealth patents
Telehealth provider Teladoc last week accused Amwell of infringing on its patents and demanded that…
Opinion: The White House Coronavirus Task Force needs to stop hiding its weekly reports from the public
Since June, the White House Coronavirus Task Force has been compiling detailed reports on how…
.jpg)
Opinion: Give teachers high priority access to Covid-19 treatments and vaccines
The Covid-19 pandemic has revealed what far too few Americans acknowledge about schools and teachers:…
Not trusting the FDA, Black doctors’ group creates panel to vet Covid-19 vaccines
As trust in federal health agencies has withered over the last few months, a group…
How Pinterest beat back vaccine misinformation — and what Facebook could learn from its approach
The battle over misinformation amid the Covid-19 pandemic has pitted health experts, parts of the…
STAT Plus: Amgen’s KRAS-blocking cancer drug shows durable responses, with tempered expectations
Amgen said Sunday that patients with advanced lung cancer who were given its drug to…
STAT Plus: New drug combination extends survival with advanced kidney cancer. It’s poised to enter a competitive treatment market
Patients with advanced kidney cancer live longer when treated with a combination of drugs from…
STAT Plus: Promising results for previously secret cancer drug data that ‘justified’ Gilead Sciences’ $21 billion acquisition
When Gilead Sciences announced its $21 billion acquisition of Immunomedics one week ago, Gilead executives…
STAT Plus: Pharmalittle: Roche says its drug helped Covid-19 patients; Trump expected to finalize drug importation plan
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Three lessons from Covid-19 on accelerating biopharma innovation
The health care research ecosystem has shifted into overdrive in response to Covid-19, sparking unprecedented…
Opinion: How the CDC and others are failing Black women during childbirth
The alarming number of deaths of Black women during childbirth and soon afterward once gained…
An expert’s take on what the U.S., U.K did wrong in Covid-19 communications — and what others did right
Some governments have been praised for being forthright about being science-driven in the way they’ve…
STAT Plus: 5 takeaways from venture capital’s growing focus on mental health
Research suggests that only half of the tens of millions of people in the U.S….
State treasurers urge Gilead to lower the price of remdesivir and not pursue “unreasonable profits”
Nearly a dozen state treasurers are asking Gilead Sciences (GILD) to lower the price of…
Listen: The CDC’s credibility crisis, pandemic PR, and virtual conference malaise
How should governments talk about Covid-19? Can the Centers for Disease Control and Prevention rebuild…
Trump’s attacks highlight CDC’s stumbles on public health messaging
WASHINGTON — Robert Redfield’s statement was unambiguous: A Covid-19 vaccine, he said, might not be…
STAT Plus: Amwell rides IPO wave with expanded stock sale
Taking advantage of a pickup in demand for new stocks, American Well Corp. expanded its…
Virtual Event: Getting real-world data about Covid-19
Editor’s note: A live stream of this virtual event will be embedded above today at…
STAT Plus: Pharmalittle: Biden-aligned group releases drug-pricing plan; U.S. to ship Covid-19 vaccines lickety-split
Rise and shine, everyone, another busy day is on the way. Most days are quite…
STAT Plus: Biden-aligned group outlines potential Day 1 drug pricing actions
WASHINGTON — A leading think tank aligned with the Democratic Party is laying the groundwork…
Opinion: A vaccine alone won’t stop Covid-19. We also need a trusted plan for it
Safe and effective vaccines represent the most effective way to restore the health and economic…
‘They are really afraid’: Fears about Covid-19 are complicating care for patients with sickle cell
Last November, just as the novel coronavirus was beginning its deadly trajectory through China, the…
STAT Plus: The cost of Gilead’s HIV prevention pill thwarted widespread use, study finds
The escalating cost of the only HIV prevention pill may have been a key factor…
STAT Plus: In research on pigs, scientists test a new way to boost recovery after a heart attack
Scientists have developed a new strategy that uses exosomes — tiny, RNA-loaded packets that cells…
STAT Plus: With Grail in its sights, Illumina pursues grand vision that could reshape the business of cancer diagnoses
Illumina, the dominant maker of machines to sequence DNA, is in talks to purchase Grail,…